Drug intelligence / Profile preview

N-[(cyclohexylamino)carbonyl]glycine

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-[(Cyclohexylamino)carbonyl]glycine is a small molecule experimental compound with the molecular formula C9H16N2O3 and a molecular weight of approximately 200.23 g/mol. It is structurally characterized as an alpha amino acid derivative bearing a carbamoyl group at its terminal nitrogen atom, specifically substituted with a cyclohexyl group. The compound has been identified as an inhibitor of bifunctional epoxide hydrolase 2 (also known as soluble epoxide hydrolase or EPHX2), suggesting potential utility in modulating pathways involving this enzyme. There are no approved indications or clinical trial phases reported for this molecule, and it remains classified as experimental[1][5][7].

Other names
N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE2-(cyclohexylcarbamoylamino)acetic acid2-(3-cyclohexylureido)acetic acidGlycine, N-[(cyclohexylamino)carbonyl]-4-(3-cyclohexyluriedo)-ethanoic acid[(cyclohexylcarbamoyl)amino]acetic acidN-(cyclohexylcarbamoyl)glycine
02

Targets

EPHX2 (Soluble epoxide hydrolase)

Beyond the preview

Go deeper on N-[(cyclohexylamino)carbonyl]glycine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[(cyclohexylamino)carbonyl]glycine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call